Announcements Trials
Browse Landscape

Status

Recruiting 4Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 13Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 5Prostatic Neoplasms 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lung Neoplasms 2Liver Neoplasms 2Glioblastoma 2Fibrosis 2Colorectal Neoplasms 2Cachexia 2Vascular Malformations 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency, Chronic 1Recurrence 1Pneumonia 1Ovarian Neoplasms 1Ovarian Cysts 1Osteosarcoma 1Obesity 1

Interventions

Gemcitabine 8Capecitabine 6pembrolizumab 5Carboplatin 5Pemetrexed 3Paclitaxel 3Oxaliplatin 3Irinotecan 3regorafenib 2osimertinib 2Taxes 2Sunitinib 2Radiotherapy 2Fluorouracil 2Cisplatin 2130-nm albumin-bound paclitaxel 2trifluridine tipiracil drug combination 1tislelizumab 1tegafur-gimeracil-oteracil 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1sintilimab 1seribantumab 1selinexor 1ruxolitinib 1rubitecan 1pralsetinib 1palbociclib 1olaparib 1niraparib 1linifanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adenocarcinoma × Blood Specimen Collection × Clear all
NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡